Structure | Chemical Name | CAS | MF |
|
TRANS,TRANS-4''-(4''-PROPYL-BICYCLOHEXYL-4-YL)-3,4,5-TRIFLUOROBIPHENYL
|
137529-41-0
|
C27H33F3
|
|
TRANS,TRANS-4''-(4''-PENTYL-BICYCLOHEXYL-4-YL)--3,4,5-TRIFLUOROBIPHENYL
|
137529-43-2
|
C29H37F3
|
|
1,2,3-trifluoro-5-(4-(2-(4-ethylcyclohexyl)ethyl)cyclohexyl)benzene
|
137529-57-8
|
C22H31F3
|
|
Aids005680
|
137530-41-7
|
C8H10FN3O3S
|
|
5-bromo-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
|
137530-43-9
|
|
|
L-N-(N-hydroxy-2-isobutylsuccinamoyl)seryl-L-valine
|
137530-61-1
|
C16H29N3O7
|
|
(4R,5R)-(-)-2,2-DIMETHYL-ALPHA,ALPHA,ALPHA',ALPHA'-TETRA(1-NAPHTHYL)-1,3-DIOXOLANE-4,5-DIMETHANOL
|
137536-94-8
|
C47H38O4
|
|
Ethanone, 1-(5-hydroxy-1H-benzimidazol-4-yl)- (9CI)
|
137538-55-7
|
C9H8N2O2
|
|
1-Propanone,1-(5-hydroxy-1H-benzimidazol-4-yl)-(9CI)
|
137538-56-8
|
C10H10N2O2
|
|
Ethanone, 1-(5-hydroxy-2-methyl-1H-benzimidazol-4-yl)- (9CI)
|
137538-57-9
|
C10H10N2O2
|
|
Piperazine, 1-methyl-3-(phenylmethyl)- (9CI)
|
137539-25-4
|
C12H18N2
|
|
buame
|
137539-90-3
|
C22H33NO
|
|
oprin
|
137540-00-2
|
C19H20FN7O2S
|
|
(4R)-4-T-BUTYL-2-METHYL 2-OXAZOLINE
|
137542-74-6
|
C8H15NO
|
|
Tetrachlorophenols, alkyl* amine salt *(as in fatty acids of coconut oil)
|
137543-70-5
|
|
|
halysin
|
137544-79-7
|
|
|
2-Chloro-5-diMethylaMino benzoic acid Methyl
|
137548-16-4
|
C10H12ClNO2
|
|
3-(4-aminophenyl)-3-cyclohexylpiperidine-2,6-dione
|
137548-41-5
|
|
|
nicotinylalanine
|
137548-54-0
|
|
|
2,4-dibromo-17-acetylestradiol
|
137548-56-2
|
|
|
F-Quene 1
|
137550-81-3
|
C25H22FN3O8
|
|
2-(3-(5-dimethylaminonaphthalene-1-sulfonyl)aminopropyl-1-oxyl)-4-((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carboxamido)benzoic acid
|
137550-88-0
|
C37H43N3O6S
|
|
annomontacin
|
137550-92-6
|
C37H68O7
|
|
Poricoic acid A(F)
|
137551-38-3
|
C31H46O5
|
|
poricoic acid B
|
137551-39-4
|
C30H44O5
|
|
deutzicoside A
|
137551-41-8
|
C40H64O12
|
|
deutzicoside B
|
137551-42-9
|
C47H76O17
|
|
3-betulinic acid 3-O-sulfate 28-O-(rhamnopyranosyl(1-4)-O-glucopyranosyl(1-6))-glucopyranoside
|
137553-03-8
|
C48H78O20S
|
|
2-FLUORO-4-IODOBENZONITRILE
|
137553-42-5
|
C7H3FIN
|
|
7-BROMO-2,4-DIAMINOQUINAZOLINE
|
137553-43-6
|
C8H7BrN4
|
|
4-AMINO-5-FLUOROQUINAZOLINE
|
137553-48-1
|
C8H6FN3
|
|
D-threo-Pentose, 4,5-dideoxy-2,3-O-(1-methylethylidene)- (9CI)
|
137553-93-6
|
C8H14O3
|
|
1-Piperazineethanamine,N,4-diethyl-(9CI)
|
137554-11-1
|
C10H23N3
|
|
1-Piperazineethanamine,N-ethyl-(9CI)
|
137554-12-2
|
C8H19N3
|
|
1-Piperazineethanamine,N-(2-methyl-2-propenyl)-(9CI)
|
137554-23-5
|
C10H21N3
|
|
Isopropylidene N-(3-hydroxy-2-pyridyl)aminomethylenemalonate
|
137557-18-7
|
C12H12N2O5
|
|
eurystatin A
|
137563-63-4
|
C23H38N4O5
|
|
eurystatin B
|
137563-64-5
|
C24H40N4O5
|
|
14-(R,S)-TOSYLOXY-6-THIAHEPTADECANOIC ACID BENZYL ESTER
|
137564-70-6
|
C30H44O5S2
|
|
14(R,S)-FLUORO-6-THIAHEPTADECANOIC ACID
|
137564-72-8
|
C16H31FO2S
|
|
L-Asp-L-Lys-L-Phe-L-Val-Gly-N-methyl-L-Leu-L-Nle-NH2
|
137565-28-7
|
C39H65N9O9
|
|
PLATELET ACTIVATING FACTOR-16, ANTAGONIST
|
137566-83-7
|
C30H62NO7P
|
|
22,23-dihydrospinasterone
|
137567-08-9
|
|
|
(4S,5S)-4,5-Bis(methoxycarbonyl)-1,3-dioxolane
|
137568-30-0
|
C7H10O6
|
|
(R)-(-)-2,2'-Bis(p-toluenesulfonyloxy)-1,1'-binaphthalene
|
137568-37-7
|
C34H26O6S2
|
|
2-(β-D-Glucopyranosyl)-1,1',3,4',6,7,8'-heptahydroxy-6'-methoxy[4,2'-bi[9H-xanthene]]-9,9'-dione
|
137570-21-9
|
C33H26O17
|
|
contignasterol
|
137571-30-3
|
C29H48O7
|
|
METHYL 3-[(PHENYLTHIO)METHYL]BENZOATE
|
137571-38-1
|
C15H14O2S
|
|
5 7-DIHYDROXY-2 2-DIMETHYL-4H-1 3-BENZO&
|
137571-73-4
|
C10H10O5
|
|
cycloheximide sensitivity factor
|
137573-73-0
|
|
|
2-BROMO-1-(5-METHYL-1-PHENYL-1H-PYRAZOL-4-YL)-1-ETHANONE
|
137577-00-5
|
C12H11BrN2O
|
|
phlinoside E
|
137578-58-6
|
C36H48O19
|
|
2-Oxazolidinethione, 3-(2-methyl-1-oxopropyl)- (9CI)
|
137578-87-1
|
C7H11NO2S
|
|
5H,8aH-Thiazolo[2,3-b][1,3]oxazin-3(2H)-one,2-ethoxydihydro-,trans-(9CI)
|
137578-96-2
|
C8H13NO3S
|
|
5H,8aH-Thiazolo[2,3-b][1,3]oxazin-3(2H)-one,2-ethoxydihydro-,cis-(9CI)
|
137578-97-3
|
C8H13NO3S
|
|
1 3-DIISOPROPYLIMIDAZOLINIUM TETRAFLUOR&
|
137581-18-1
|
C9H19N2.BF4
|
|
1 3-DI-TERT-BUTYLIMIDAZOLINIUM TETRAFLU&
|
137581-21-6
|
C11H23N2.BF4
|
|
(S)-ALPHA-PHENYL-1-PYRROLIDINEETHANAMINE
|
137581-63-6
|
C12H18N2
|
|
Methyl 2-amino-2-benzyl-3-phenylpropanoate
|
137582-40-2
|
C17H19NO2
|
|
2-Ethanediamine,N-2-pyrimidinyl-
|
137583-05-2
|
C6H10N4
|
|
L-Isovaline, 3-Methyl-N-[(phenylMethoxy)carbonyl]-
|
137584-40-8
|
C14H19NO4
|
|
1-vinyl-3-methylimidazole-maleic acid diethyl ester copolymer
|
137587-42-9
|
C14H21IN2O4
|
|
1-(2-CHLOROPHENYL)BIGUANIDE HYDROCHLORIDE
|
137588-53-5
|
C8H11Cl2N5
|
|
(-)-(5R,3R,2R)-5-(1-HYDROXY-1-METHYLETHYL)-3-CYANO-2-METHYLCYLOHEXANONE
|
137588-59-1
|
C11H17NO2
|
|
Acetamide, N-(5-amino-4-fluoro-2-hydroxyphenyl)-
|
137589-58-3
|
C8H9FN2O2
|
|
(8a,9R)-Cinchonan-9-ol mono[[(S)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetate]
|
137590-32-0
|
C19H29O6P.C19H22N2O
|
|
MAGNESIUMPOTASSIUMCITRATE
|
137590-34-2
|
C12 H10 K4 Mg O14
|
|
Taxifolin 7-rhamnoside
|
137592-12-2
|
C21H22O11
|
|
hypocrellin C
|
137592-26-8
|
C30H26O9
|
|
BISINDOLYLMALEIMIDE III
|
137592-43-9
|
C23H20N4O2
|
|
BISINDOLYLMALEIMIDE II
|
137592-45-1
|
C27H26N4O2
|
|
BISINDOLYLMALEIMIDE VII
|
137592-47-3
|
C27H27N5O2
|
|
1-O-galactopyranosyl-N-(10-(1-pyrene-9-enedecanoyl)sphingosine)
|
137593-41-0
|
C50H71NO8
|
|
parathyroid hormone (68-84)
|
137593-42-1
|
C78H133N21O27
|
|
glutathione maleimide
|
137593-43-2
|
C14H17N3O8S
|
|
isoleucyl-histidyl-leucyl-valyl-prolyl-carboxyamidomethylcysteinyl-arginine
|
137593-44-3
|
C39H67N13O9S
|
|
octenoylpenicillin
|
137593-45-4
|
C16H24N2O4S
|
|
toxic shock syndrome toxin-1 (58-78)
|
137593-46-5
|
C98H171N33O35
|
|
GR 64349
|
137593-52-3
|
C42H68N10O11S
|
|
Quinoline, 6-fluoro-3-methyl- (9CI)
|
137595-46-1
|
C10H8FN
|
|
alpha(A) globin
|
137597-31-0
|
|
|
ribosomal protein S28
|
137597-93-4
|
|
|
ProNectin F
|
137599-18-9
|
|
|
3,5-DIISOBUTYL-4-(2-METHOXYBENZOYL)-OXO-TOLUENE
|
137600-70-5
|
C23H30O3
|
|
bromorebeccamycin
|
137605-02-8
|
C27H21Br2N3O7
|
|
3-(MORPHOLIN-4-YLMETHYL)BENZOIC ACID HYDROCHLORIDE HYDRATE
|
137605-80-2
|
C12H15NO3.ClH
|
|
2-BUTYL-2-ETHYL-1 5-PENTANEDIAMINE
|
137605-95-9
|
C11H26N2
|
|
3-hydroxy-beta-ionol-glucopyranosyl(1-6)glucopyranoside
|
137606-56-5
|
C25H42O12
|
|
5-acetamido-2-[2-[5-acetamido-2-[[5-acetamido-2-carboxy-4-hydroxy-6-(1,2,3-trihydroxypropyl)oxan-2-yl]oxymethyl]-6-[2-[[3-acetamido-4-hydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,5-dihydroxy-6-(1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxyoxan-4-yl]oxy-3-hydroxyoxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid
|
137608-62-9
|
C62H102N4O47
|
|
4,8-dihydro-4-hydroxy-8-oxo-2'-deoxyguanosine
|
137608-89-0
|
|
|
Benzamide, N,N-diethyl-3,4-dihydroxy- (9CI)
|
137609-03-1
|
C11H15NO3
|
|
5-[4-(DIMETHYLAMINO)PHENYL][1,3]THIAZOLO[4,3-B][1,3,4]THIADIAZOL-2-AMINE
|
137609-29-1
|
C12H14N4S2
|
|
4-Pyridazinecarboximidic acid, 3-amino-, hydrazide
|
137609-33-7
|
C5H8N6
|
|
2-CHLORO-6-METHOXY-QUINOLINE-3-CARBOXYLIC ACID
|
137612-85-2
|
C11H8ClNO3
|
|
12H-QUINO[2,3-B][1,5] BENZO DIAZEPIN-12-ONE, 5,11-DIHYDRO-
|
137612-86-3
|
C16H11N3O
|
|
1H-Pyrazole-4-carbonyl chloride, 3-cyclobutyl-1-methyl- (9CI)
|
137614-14-3
|
C9H11ClN2O
|
|
3-cyclopropyl-1-Methyl-pyrazole-4-carboxylic acid
|
137614-47-2
|
C8H10N2O2
|
|
BOC-(RS)-3-AMINO-1,2-PROPANEDIOL
|
137618-48-5
|
C8H17NO4
|
|
Propanamide, 2,3-dihydroxy-N,N-dimethyl- (9CI)
|
137618-50-9
|
C5H11NO3
|
|
Benzoic acid, 4-Methyl-, 2-Methylbutyl ester
|
137619-80-8
|
C13H18O2
|